Patent ID: 9358292
Filing Date: 2016-06-07
CPC Classification: A61F,A61H,A61K,A61N,A61P

Claim Text:
1. A method for treating cancer in a subject, comprising: (1) administering to the subject a pharmaceutical agent comprising at least one of 8-methoxypsoralen (8-MOP) and 4′-aminomethyl-4,5′,8-trimethylpsoralen (AMT) that causes a cellular change when activated; (2) administering to the subject at least one energy modulation agent comprising a phosphorescent agent that, upon reception of X-ray energy, emits light that activates the pharmaceutical agent; wherein the at least one energy modulation agent and the pharmaceutical agent are independent and separately movable from each other; and (3) applying the X-ray energy from an X-ray energy source to the subject, and wherein the at least one energy modulation agent activates the pharmaceutical agent in situ with said light emitted from the phosphorescent agent, thus causing the cellular change to occur, wherein said cellular change treats by inducing apoptosis in cancer cells.